Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
June 2, 2020 - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2019 Environmental, Social and Governance (ESG) Progress Report
Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries Ltd. and Direct Relief announced today a donation partnership that will provide access to medications in sub-Saharan Africa—where an overwhelming majority of pediatric ca...
A message from our CEO, Kåre Schultz
Teva has a rich history of providing innovative, high-quality generic and specialty drugs and health solutions to patients around the world every day. Since joining the company late last year, I’ve been motivated by the opportunity to advance thi...
Today, two leading private sector groups announced a partnership to create scalable solutions to improve patient and health system care for Multiple Chronic Conditions.
The initiative was announced to an audience of public health leaders at the World Economic Forum’s (WEF) Sustainable Deve...
In 2016, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) engaged more than 300,000 people in 35 countries in programs aimed to help and empower patients as they deal with their illnesses.
These patient support programs are among the outcomes of broader efforts...
Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced the U.S. organizations selected as part of Teva’s 2017-18 Community Partnership Program. Now in its fourth year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that s...
Teva Pharmaceuticals is now accepting entries for the 2017-18 Teva Community Partnership Program. Now in its third year, this exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that support patients and their caregivers and...